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Agaricus blazei Murrill from Brazil: an ingredient
for nutraceutical and cosmeceutical applications
Oludemi Taoﬁq, a,b,c Francisca Rodrigues, d Lillian Barros, a Rosane M. Peralta,e
Maria F. Barreiro,a,b Isabel C. F. R. Ferreira *a and M. Beatriz P. P. Oliveira d
Operations for sorting mushrooms at the industrial level usually generate large amounts of bio-residues
not conforming to strict morphological criteria for commercial purposes, even though their biological
content is not compromised. In this context, the present work aimed at evaluating the potential for reuti-
lizing industrially discarded Agaricus blazei Murill (ABM). Thus, the content of essential nutrients and the
chemical composition were determined, and MTT and LDH assays were used to evaluate the viability and
cell death of Caco-2 and HT29 cell lines of an ethanolic extract prepared from ABM (preliminary safety
tests for nutraceutical applications). The extract was incorporated into a semi-solid base cosmetic cream
and cell viability eﬀects of the extract, and of the ﬁnal cream formulation, on a keratinocyte cell line
(HaCaT) were studied (preliminary safety tests for cosmeceutical applications). Essential nutrients, such as
proteins and carbohydrates, and a low fat content were determined for ABM. Twenty-two fatty acids were
detected, with polyunsaturated fatty acids (PUFA) (∼53%) being the most abundant fraction. The cell viabil-
ities of Caco-2 and HT29 cells were maintained up to 100 µg mL−1. After incorporation into the base
cream, a formulation with a pale yellow colour and favourable pH was obtained. The cell viability of
HaCaT cells in the presence of the extract and the ﬁnal cream formulation was maintained in a concen-
tration dependent manner, which indicates the safety of this extract for cosmeceutical applications. The
results suggest that ABM residues can be used as an inexpensive and sustainable source of nutraceutical
and cosmeceutical ingredients.
1. Introduction
The concept of bio-economy has emerged to overcome sustain-
ability challenges involving the conversion of biological
wastes, agricultural residues and waste streams into high
value-added products that can be employed as ingredients for
several bio-based industrial processes, delivering scientific
interest, a safe environment, and economic growth.1,2
Agricultural bio-residues are generated at several stages of the
food supply chain, namely the primary production, processing,
retailing and consumption. The most significant wastes are
obtained during production and processing stages due to
several pre-harvest or post-harvest conditions.3
Mushrooms are globally consumed not only because of
their nutritional properties but also due to their medicinal
potential and, more recently, they are increasingly used as cos-
meceutical ingredients because they are rich in several bio-
active compounds.4–6 Agaricus blazei Murrill (ABM) is a medic-
inal mushroom popularly referred to as ‘Cogumelo do Sol’ in
Brazil, ‘Himematsutake’ in Japan, and ‘Ji Song Rong’ in China;
it is rich in polysaccharides, phenolic acids and ergosterol.7 In
recent years, ABM extracts have become increasingly popular
because of their long history as treatments for diseases, associ-
ated with their anti-cancer, immunomodulatory, anti-inflam-
matory, antitumor, antioxidant and antiviral properties.8,9
This species is sometimes consumed in tea and other bev-
erages, generating a lot of waste and by-products. Most impor-
tantly, its sorting at the industrial level usually generates bio-
residues not conforming strictly to morphological criteria for
commercial purposes, even though their content in valuable
biomolecules is not compromised.10 These residues can be an
important source of high value-added bioactive compounds,
which can be further utilized as ingredients for several bio-
based applications.7
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Bioactive compounds are becoming increasingly used as
nutricosmetic and cosmeceutical ingredients due to their
important skin health promoting properties. The former
involves the oral ingestion of dietary supplements, or extracts
rich in bioactive molecules, reducing the impact of free rad-
icals and producing positive skin appearance benefits. The
latter corresponds to cosmetic products, either in the form of
cream or lotions, containing biologically active molecules that
confer a medical drug-like eﬀect.4,11–13 These trends are being
successively described as eﬀective, even though some research
scientists continue to be skeptical and see them as a market-
ing twist. Commercially, nutraceutical and cosmeceutical pro-
ducts formulated from diﬀerent mushroom extracts can be
already found, either alone or combined with other mushroom
species, but to the best of our knowledge Agaricus blazei has
not yet been exploited. Their successful use and commerciali-
zation depend on the safety, purity and eﬃcacy of the derived
products, such as diﬀerent types of extracts.
The present work was carried out to evaluate the potential
to reutilize industrially discarded Agaricus blazei Murill by
assessing its nutraceutical and cosmeceutical potential.
Ethanolic extracts, obtained by Soxhlet extraction, were evalu-
ated regarding their eﬀects on cell viability and death in Caco-
2 and HT29 cell lines (MTT and LDH assays; preliminary safety
tests for nutraceutical applications). To evaluate its dermatolo-
gical potential, the extract was incorporated into a semi-solid
base formulation that, together with the ethanolic extract
itself, was studied for its eﬀects on the cell viability of a kerati-
nocyte cell line (preliminary safety tests for cosmeceutical
applications).
2. Material and methods
2.1. Mushroom bio-residues
The fruiting bodies (basidiocarps) of Agaricus blazei Murrill
(ABM) were donated by a local producer in Maringá, Paraná,
Brazil (23°24′S 51°55′W). Those ABM fruiting bodies that were
considered oﬀ-market and grouped as an agro-industrial
residue were used in the present work.10 The samples were
oven dried, milled to obtain a fine powder (∼40 mesh) and
mixed to obtain a homogeneous sample. For all the performed
tests, three samples were analysed, and all the assays were
carried out in triplicate. The results are expressed as the mean
values ± standard deviation (SD).
2.2. Analysis of the nutritional and chemical composition of
ABM bio-residues
Proximate composition. Proteins, fat, carbohydrates and ash
were determined using standard AOAC procedures.14 The
sample’s crude protein content (N×4.38) was estimated by the
Kjeldahl method; the crude fat was determined by Soxhlet
extraction using a known weight of the sample and petroleum
ether as the solvent; the ash content was determined by incin-
eration at 600 ± 15 °C. Total carbohydrates were calculated by
diﬀerence and the energy content was estimated using the fol-
lowing equation: Energy (kcal) = 4 (g protein) + 4 (g carbo-
hydrate) + 9 (g fat).
Free sugars composition. Free sugars were identified and
quantified using high performance liquid chromatography
coupled to refractive index detection (HPLC-RI).15
Quantification was based on calibration curves obtained from
the commercial standards (D(−)-fructose, D(−)-mannitol,
D(+)-raﬃnose pentahydrate and D(+)-trehalose (Sigma-Aldrich,
St. Louis, MO, USA) using the internal standard (IS, raﬃnose)
methodology. The results were recorded and processed using
Clarity 2.4 software (DataApex, Prague, Czech Republic), and
sugar contents were expressed in g per 100 g dry weight (dw).
Fatty acids composition. Samples (1.5 g) were extracted
using a Soxhlet apparatus with petroleum ether as solvent. The
samples undergo transesterification according to a procedure
previously reported by the authors.15 Fatty acid identification was
made by a comparison with relative retention times of standards
(standard 47885-U, Sigma-Aldrich). The results were recorded
and processed using CSW 1.7 software (DataApex 1.7, Prague,
Czech Republic), and expressed in relative percentage (%).
Tocopherol composition. Tocopherols were determined by
HPLC with fluorescence detection (FP-2020; Jasco, Easton,
MD, USA), using excitation at 290 nm and emission at
330 nm.15 Quantification was done based on calibration curves
obtained from commercial standards (α-, β-, γ-, and
δ-tocopherols; Matreya, Pleasant Gap, PA, USA) using the IS
(tocol; Matreya) methodology. The results were recorded and
processed using Clarity 2.4 software (DataApex, Prague, Czech
Republic) and expressed in mg per 100 g dw.
Organic acid composition. Samples (1.5 g) were extracted
according to a procedure described by the authors.16 Analysis
was performed using a Shimadzu 20A series UFLC (Shimadzu
Corporation) coupled to a diode array detector (DAD).
Quantification was made using calibration curves, obtained at
215 nm, from commercial standards (citric, malic, oxalic, shi-
kinic, succinic, fumaric and quinic acids; Sigma-Aldrich). The
results were recorded and processed using LabSolutions Multi
LC-DAD software (Shimadzu Corporation, Kyoto, Japan) and
expressed in g per 100 g dw.
2.3 Preparation of the AMB ethanolic extract
The powdered samples (3.0 g) were extracted with 100 mL of
ethanol under reflux in a Soxhlet apparatus. The obtained
extract solutions were filtered (Whatman paper no. 4) and the
solvent was evaporated under reduced pressure. The extraction
yield was expressed as percentage (%, w/w) relative to the
weight of the used dry sample.
2.4. Incorporation of the ABM ethanolic extract into a semi-
solid cosmetic base cream
A cosmetic semi-solid formulation purchased from Fagron
Iberica S.A.U. (Barcelona, Spain) was used in the present work.
The formulation was supplemented separately with the extract
at a percentage of 2.5%, which corresponds to 25 mg per gram
of base cream, as previously described by the authors.17 The
formulation was mixed properly to ensure sample homogenis-
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ation and then stored in tightly closed vials at 4 °C. The colour
and pH parameters were measured according to a procedure
previously reported by the authors.18 Namely, the cosmeceuti-
cal formulation colour was determined using a colorimeter
(model CR-400; Konica Minolta Sensing Inc., Tokyo, Japan) by
sampling at three diﬀerent points, and the average was con-
sidered for the true colour value. Colour space values were
recorded using the data software “Spectra Magic Nx” (version
CM-S100W 2.03.0006). The pH determination was performed,
in triplicate, directly in the cream using a HI 99161 pH meter
(Hanna Instruments, Woonsocket, Rhode Island, USA).
2.5. Preliminary safety tests for nutraceutical and
cosmeceutical applications
Cell lines and culture conditions. The human immortalized
non-tumorigenic keratinocyte cell line HaCaT (Ethnicity,
Caucasian; age, 62 years; gender, male; tissue, skin) was sup-
plied by CLS Cell Lines Service, Germany. Caco-2 cells were
obtained from the American Type Culture Collection (ATCC,
USA) and the HT29-MTX cell line was kindly provided by Dr T.
Lesuﬄeur (INSERM U178, Villejuif, France). Each cell line was
grown separately in tissue culture flasks (Orange Scientific,
Belgium). Cell lines were grown in DMEM (Carlsbad, CA) forti-
fied with L-glutamine, 10% inactivated fetal calf serum (FBS),
an antibiotic–antimitotic mixture (final concentration of 100
U mL−1 penicillin and 100 U mL−1 streptomycin) maintained
in a 5% CO2 incubator (Cell Culture® CO2 Incubator, ESCO GB
Ltd, UK). At 90–95% confluence, cells were trypsinized and
plated in microtiter dishes. The viable cells were counted
using the trypan blue dye (Gibco) using a hemocytometer.
Caco-2 and HT29-MTX cell lines were used to evaluate the
ethanolic extract’s safety in nutraceutical ingredients, while
the HaCaT cell line was used to evaluate the safety of both the
ethanolic extract and the final cream formulation in cosmeceu-
tical applications.
Two diﬀerent assays were used to assess the eﬀects on cell
integrity: (1) monitoring the uptake of the vital mitochondrial
dye, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTT), by cell mitochondria
and (2) determining the leakage of the cytosolic enzyme,
lactate dehydrogenase (LDH), into the cell medium (LDH
assay). For the cell treatment, samples were dissolved in
DMEM and subsequent dilutions were prepared from
1 µg mL−1 to 10 mg mL−1. In both tests, triplicate wells were
incubated with a fresh medium in the absence, or presence, of
test samples.
MTT assay. Cell viability was assessed using the 3-(4,5-di-
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium (MTT; purchased from Promega, Madison, WI)
conversion assay.19 Cells were cultured in 96-well microtiter
plates at a density of 25 × 103 cells per mL culture medium for
24 h. Then, cells were incubated with 1 µg mL−1 to 10 mg mL−1
of both extracts and their corresponding formulations for 24 h
at 37 °C. After the removal of samples from the wells, cells
were washed with phosphate-buﬀered saline, followed by the
addition of a fresh medium. The microtiter plates were
then incubated under a humidified atmosphere of 5% CO2 at
37 °C for 24 h. To evaluate the number of viable cells, 100 µL
of MTT solution was added to each well and incubated for 4 h
at 37 °C in the dark. Then, the medium was removed, and the
intracellular formazan crystals were solubilized and extracted
with 100 µL dimethylsulfoxide (DMSO). After 15 min under
continuous stirring at room temperature, the absorbance was
measured at 490 nm with background subtraction at 630 nm
in a Synergy HT Microplate Reader (BioTek Instruments, Inc.,
Winooski, VT).
LDH assay. Briefly, cell lines were seeded in 96-well plates
and cultured for 48 h. Ethanolic extracts at diﬀerent concen-
trations were prepared in an appropriate medium and added
to the cells. After incubation (37 C/5% CO2), cells were washed
twice with PBS (pH 7.4) and the LDH kit (Takara Bio Inc.,
Shiga, Japan) was used according to the manufacturer’s
instructions.19 To determine the maximum LDH release (high
control), some cells were solubilized with a final concentration
of 1% (w/v) Triton X-100 (Boehringer Mannheim). The absor-
bance was measured at 490 nm with background subtraction
at 690 nm using a Synergy HT Microplate Reader (BioTek
Instruments, Inc., Winooski, VT). Each concentration was
tested in triplicate in three independent experiments.
3. Results and discussion
3.1. Nutraceutical potential and chemical composition of
ABM bio-residues
Studies on the chemical and bioactive composition of mush-
rooms have been reported over the years, aiming at identifying
species with relevant biological properties and high nutritional
value.6,20,21 The proximate composition of the studied ABM
bio-residues, expressed on a dry weight (dw) basis, is pre-
sented in Table 1. Its components include carbohydrates (48 ±
2 g per 100 g dw), crude protein (31.6 ± 0.5 g per 100 g dw),
ash (6.2 ± 0.5 g per 100 g dw), and total fat (0.66 ± 0.08 g per
100 g dw). Carbohydrates were the major constituents,
followed by proteins and ash; the fat content was low. The
energy contribution was 325.3 ± 0.5 kcal per 100 g dw, mainly
Table 1 Nutritional and chemical composition of ABM bio-residues
Component Mean ± SD
Nutritional value (g per 100 g)
Lipids 0.66 ± 0.08
Proteins 31.6 ± 0.5
Ash 6.2 ± 0.5
Carbohydrates 48 ± 2
Energy (kcal per 100 g) 325.3 ± 0.5
Free sugars (g per 100 g)
Mannitol 34.4 ± 0.2
Trehalose 5.1 ± 0.2
Total sugars 39.5 ± 0.4
Tocopherols (µg per 100 g)
α-Tocopherol 17 ± 0.6
Organic acids (g per 100 g)
Oxalic acid 0.98 ± 0.01
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attributed to the high carbohydrates content. Compared with a
commercial A. blazei supplement obtained from Brazil, there
was no significant diﬀerence in the nutritional profile (ash,
7.47 ± 0.04 g per 100 g dw; proteins, 31 ± 2 g per 100 g dw; fat,
1.82 ± 0.03 g per 100 g dw).22 Regarding free sugars, mannitol
and trehalose were the only ones detected, and were found in
similar amounts to the ones reported by Stojković et al.23 In
what concerns organic acids, oxalic acid was the unique
detected compound, even though Stojković et al.23 reported
the presence of fumaric acid in A. blazei samples obtained
from another geographical origin, the Netherlands. Regarding
the fatty acids profile, twenty-two molecules were identified
(Table 2), with polyunsaturated fatty acids (PUFA) predominat-
ing (a high contribution of linoleic acid was identified), fol-
lowed by saturated fatty acids (SFA) and monounsaturated fatty
acids (MUFA). The distribution of fatty acids in the studied
dried powder mushroom were similar to the ones reported by
Carneiro et al.22
Most of the literature reports refer to intact fruiting bodies
of ABM, while the present results show that discarded bio-resi-
dues are still promising sources of interesting biomolecules.
To the best of the our knowledge, only Corrêa et al.10 have
reported the reutilisation of ABM bio-residues to produce an
ergosterol rich fraction with antioxidant and antimicrobial pro-
perties. Those authors went further by fortifying a commercial
yoghurt with the obtained ergosterol rich extract, and the final
formulation was found to present an enhanced antioxidant
activity. ABM is therefore considered a complete “package” of
healthy food, being a useful source of nutritional components
as well as non-nutritional compounds, which can be orally
ingested or used as food supplements to improve the wellbeing
and function of the human body.
3.2. Preliminary safety tests with the ABM ethanolic extract
for nutraceutical ingredients
To fully confirm the nutraceutical potential of the obtained
ABM ethanolic extracts, the major challenge still lies in the
assessment of their safety throughout the gastrointestinal tract
since the intestinal epithelium is the major area for the
absorption of bioactive molecules allowing them to reach sys-
temic circulation. Hence, in vitro models were developed to
mimic the intestinal epithelium and assess the safety of bio-
active extracts.24 In the present work, the cell viability eﬀect of
the ethanolic extract prepared from ABM bio-residues on Caco-
2 and HT29-MTX cells in a concentration dependent manner
was evaluated (1–10 000 µg mL−1). Caco-2 cells are similar to
enterocytes, while HT29-MTX cells are like the mucus produ-
cing goblet cells. Both cell lines have been widely used as
intestinal models to evaluate the safety of novel nutraceutical
ingredients.25 Concerning Caco-2 cells, at 100 µg mL−1, cell
viability was not influenced up to 80% (Fig. 1). Regarding
HT29-MTX cells, up to 80% cell viability was maintained at
1 mg mL−1, while the highest tested concentration (10 mg mL−1)
was found to significantly inhibit the viability. However, above
that concentration, cell viability was significantly reduced as
shown in Fig. 2. The LDH assay has been utilised as a good
marker to ascertain the cytotoxicity of bioactive ingredients.
The mechanism behind it involves the measurement of lactate
dehydrogenase (LDH), an enzyme found in the surroundings
of compromised cell membranes. In the present work, both
Caco-2 and HT29 cells were found to have no significant eﬀect
Table 2 Fatty acids (relative percentage, %) in ABM bio-residues
Fatty acids Amount (%)
C6:0 0.225 ± 0.006
C8:0 0.459 ± 0.009
C10:0 0.319 ± 0.003
C12:0 2.36 ± 0.01
C14:0 1.36 ± 0.02
C15:0 1.22 ± 0.01
C15:1 0.056 ± 0.001
C16:0 20.6 ± 0.1
C16:1 0.170 ± 0.005
C17:0 1.34 ± 0.01
C18:0 5.58 ± 0.02
C18:1n9 2.66 ± 0.02
C18:2n6 51.04 ± 0.05
C18:3n6 1.47 ± 0.02
C20:0 1.88 ± 0.02
C20:1 0.046 ± 0.002
C20:2 0.201 ± 0.007
C21:0 0.572 ± 0.001
C22:0 4.36 ± 0.07
C22:1 2.1 ± 0.1
C23:0 0.516 ± 0.004
C24:0 1.52 ± 0.04
SFA 42.2 ± 0.1
MUFA 5.0 ± 0.1
PUFA 52.71 ± 0.02
The results are presented as the mean ± SD. Caproic acid (C6:0);
caprylic acid (C8:0); capric acid (C10:0); lauric acid (C12:0); myristic
acid (C14:0); pentadecanoic acid (C15:0); cis-10-pentadecenoic acid
(C15:1); palmitic acid (C16:0); palmitoleic acid (C16:1); heptadecanoic
acid (C17:0) stearic acid (C18:0); oleic acid (C18:1n9); linoleic acid
(C18:2n6); gamma linolenic acid (C18:3n6); arachidic acid (C20:0); cis-
11-eicosenoic acid (C20:1); cis-11,14-eicosadienoic acid (C20:2);
heneicosanoic acid (C21:0); behenic acid (C22:0); erucic acid (C22:1);
tricosanoic acid (C23:0); lignoceric acid (C24:0); SFA – saturated fatty
acids; MUFA – monounsaturated fatty acids; PUFA – polyunsaturated
fatty acids.
Fig. 1 Cell viability eﬀects of the ABM ethanolic extract at diﬀerent
concentrations on Caco-2 cells as measured by the MTS assay (n = 4).
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on LDH leakage up to 100 µg mL−1 (Fig. 3). However, the LDH
level was significantly detected in Caco-2 at 1 mg mL−1 and
10 mg mL−1. From the obtained results, the cell viability
studies in the MTT assay were consistent with what was
observed in the LDH assay.
3.3. Preliminary safety tests with the ABM ethanolic extract
and the final cream formulation for cosmeceutical applications
The global cosmetic industry has been a successful industrial
sector over the years. Due to the increased awareness, coupled
with the higher demand for safer and natural-based cosmetic
products, innovative natural ingredients that are able to
provide multifunctional benefits to the skin are of utmost
importance in this industrial sector.4,26,27 In this context,
mushroom-based cosmeceutical ingredients are gaining
increased importance, even though they are still exploited at
modest levels. Moreover, some of the bioactive properties dis-
played by mushroom extracts and/or their individual metab-
olites have led dermatologists and researchers linked to the
cosmetic field to become optimistic considering the future of
mushrooms and their compounds in this sector.
In the present work, the incorporation of the ethanolic
extract into a base cream resulted in a formulation with a
lower level of lightness (L*) when compared with the former
base cream (control). The following colour attributes using the
L*a*b* scale were obtained (74.30 ± 0.8, 9.16 ± 0.31, 19.31 ±
0.48). The final pH of the mushroom-based formulation was
4.31 ± 0.03, while for the control it was 4.84 ± 0.02. Some
studies have reported that formulations with pH between 3.5
and 6.0 can be considered to be favourable as most pathogenic
bacteria thrive best at neutral pH levels and, under these con-
ditions, the skin micro-flora and barrier homeostasis are
maintained.28,29 Additionally, some of the biomolecules identi-
fied and quantified in the studied ABM bio-residues, namely
tocopherols, fatty acids, organic acids and sugars, can play
major roles in skin antioxidant defence, protection against
photoaging, regulation of collagen synthesis, suppression of
inflammatory response, normalization of epidermal lipid pro-
files and improvement of skin hydration and elasticity.30–35
Noteworthy is the high content of mannitol detected in the
analysed ABM bioresidues (Table 1). Mannitol is largely used
in cosmetics as a humectant to preserve the product from de-
hydration, and as a moisturising agent to prevent the dryness
of the skin. In the last few years, mannitol has been con-
sidered as the ideal excipient to be used with hyaluronic acid
(HA) fillers, thanks to its hydrating and antioxidant pro-
perties.36 Thus, the action of these molecules incorporated
into the final formulation prepared herein can contribute to a
better skin function.
Even though progress has been made in what concerns the
use of natural extracts as cosmeceutical ingredients, their
safety and eﬃcacy lack appropriate reporting and dissemina-
tion. This constraint makes diﬃcult consumers’ acceptance,
since they may not perceive that bioactive claims are true. In
addition, the safety evaluation of ingredients for cosmeceutical
applications is a critical step as some of these natural extracts
contain diﬀerent compounds and biomolecules that may be
irritants to skin cells. In the present work, the eﬀects of the
obtained ethanolic extract on the cell viability of keratinocyte
(HaCaT) cells were evaluated using MTT and LDH assays, as
this cell line was previously documented as a reliable in vitro
model to assess the safety of cosmeceutical ingredients.19
From the results shown in Fig. 4 for the MTT assay, the
ABM ethanolic extract did not show cytotoxicity on the HaCaT
cell line up to 100 µg mL−1. However, at 1 mg mL−1, there was
a reduction in the cell viability up to 30%, while a significant
decrease was observed at the highest tested concentration
(10 mg mL−1). These results showed that higher concen-
trations of the extract can be deleterious for skin cells. It can
also be seen that the obtained cell viability results for the
extract were in accordance with the ones obtained with the corres-
ponding formulation, namely 50% cell viability at 1 mg mL−1
(Fig. 5). The cytotoxicities of Agaricus blazei extracts and their
individual metabolites in diﬀerent cell lines have been
reported,37–39 and in the case of Shahirah et al.,40 the in vitro
cytotoxicity eﬀect of ABM using the MTT assay in a fibroblast
cell line (V79-4) was determined. According to the authors, the
Fig. 2 Cell viability eﬀects of the ABM ethanolic extract at diﬀerent
concentrations on HT29-MTX cells as measured by the MTS assay (n = 4).
Fig. 3 Cytotoxicity eﬀects of the ABM ethanolic extract on HT29-MTX
and Caco-2 cells at diﬀerent concentrations as measured by the LDH
assay.
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extracts displayed cytotoxicity eﬀects above 1 mg mL−1, which
is consistent with the results achieved in the present work. To
the best of the authors’ knowledge, this is the first report to
evaluate the safety of ABM extracts in cosmeceutical formu-
lations, tested in a keratinocyte cell line.
4. Conclusion
The present study is the first report to evaluate the potential
for reutilisation of A. blazei by-products, based on its nutri-
tional and chemical composition, in nutraceutical and cosme-
ceutical applications. Also, the dermatological potential of an
ethanolic extract was assessed through cell viability eﬀects on
a skin cell line. The presence of essential nutrients such as
carbohydrates, proteins and fatty acids was demonstrated. The
ethanolic extract maintained the cell viability on Caco-2 and
HT29 cells at 100 µg mL−1. Being rich in sugars, α-tocopherol
and organic acids makes A. blazei by-residues a potential ingre-
dient for developing nutraceutical ingredients and/or func-
tional foods, which may contribute to better nutrition and
health improvement. It is also important to note that the oral
administration of extracts rich in compounds with antioxidant
capacity can be used to prevent the eﬀects of cutaneous sun
damage, but the eﬃcacy of these extracts as nutricosmetics
still needs to pass proper long-term clinical trials. In what con-
cerns their cosmeceutical potential, the extract was able to
maintain the cell viability in the HaCaT cell line up to 80% at
1 mg mL−1, thus pointing to their safety for keratinocytes. The
cream formulation prepared with the extract presented a light-
yellow colour and a pH of 4.31, which is considered suitable for
skin contact purposes. The biomolecules present in ABM,
namely tocopherols, fatty acids, organic acids and sugars, can
also contribute to better skin appearance. To further confirm the
cosmeceutical potential of ABM, skin permeation studies using
Franz diﬀusion cells to determine the topical bioavailability of
the active ingredients are needed, in addition to dermal and
ocular irritability tests to ascertain safety. The results presented
herein support the sustainable re-use of mushroom wastes, here
demonstrated with ABM, which are generated in significant
quantities during their production chain. This is highly meaning-
ful since global mushroom cultivation has been predicted to
increase significantly in the coming years.
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